Company Performance Metrics
BioDivide develops and manufactures cell therapies and biologics for use in veterinary medicine and companion animal health. The company engineers regenerative therapies, including its StemPlan platform, which provides frozen, ready-to-inject stem cell products derived from non-invasive sampling and expanded under controlled conditions. BioDivide
supplies veterinarians with cell therapy treatments for dogs, cats, and horses with degenerative joint and soft-tissue conditions. It also offers contract manufacturing, biotech consultancy, and advanced biologic development support. In addition, BioDivide provides biotech hosting services with fully fitted laboratories, specialist equipment, desk space, and cryostorage capabilities for other life science businesses. The company conducts cell-based assay development, in vitro disease modelling, stem cell differentiation, and cell and tissue processing to support research and product development.